These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 32056383)

  • 1. Late-onset hypogonadism: Prostate safety.
    Miranda EP; Torres LO
    Andrology; 2020 Nov; 8(6):1606-1613. PubMed ID: 32056383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone and benign prostatic hyperplasia.
    Jarvis TR; Chughtai B; Kaplan SA
    Asian J Androl; 2015; 17(2):212-6. PubMed ID: 25337845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset hypogonadism: a concept comes of age.
    Nieschlag E
    Andrology; 2020 Nov; 8(6):1506-1511. PubMed ID: 31639279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone supplementation does not worsen lower urinary tract symptoms.
    Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
    J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
    Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
    BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone and the Prostate: Artifacts and Truths.
    DeLay KJ; Kohler TS
    Urol Clin North Am; 2016 Aug; 43(3):405-12. PubMed ID: 27476133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testosterone Deficiency and the Prostate.
    Alukal JP; Lepor H
    Urol Clin North Am; 2016 May; 43(2):203-8. PubMed ID: 27132577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
    Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
    Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Association of Urology Position Statement on the Role of the Urologist in the Management of Male Hypogonadism and Testosterone Therapy.
    Mirone V; Debruyne F; Dohle G; Salonia A; Sofikitis N; Verze P; Fode M; Chapple C;
    Eur Urol; 2017 Aug; 72(2):164-167. PubMed ID: 28249799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical evaluation of different available guidelines for late-onset hypogonadism.
    Giagulli VA; Castellana M; Lisco G; Triggiani V
    Andrology; 2020 Nov; 8(6):1628-1641. PubMed ID: 32593233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone replacement therapy.
    Barbonetti A; D'Andrea S; Francavilla S
    Andrology; 2020 Nov; 8(6):1551-1566. PubMed ID: 32068334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in testosterone supplementation therapy.
    Khera M
    Asian J Androl; 2015; 17(2):175-6. PubMed ID: 25652639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Risk and Monitoring During Testosterone Replacement Therapy.
    Bhasin S; Thompson IM
    J Clin Endocrinol Metab; 2024 Jul; 109(8):1975-1983. PubMed ID: 38753865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of testosterone replacement therapy on prostate-specific antigen (PSA) levels in men being treated for hypogonadism: a systematic review and meta-analysis.
    Kang DY; Li HJ
    Medicine (Baltimore); 2015 Jan; 94(3):e410. PubMed ID: 25621688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Age-related androgen deficiency and benign prostatic hyperplasia: how to improve the rehabilitation of patients after transurethral surgery?].
    Martov AG; Ergakov DV
    Urologiia; 2016 Dec; (6):110-117. PubMed ID: 28248054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Prostate Biopsy in Men with Hypogonadism Prior or During Testosterone Replacement Therapy.
    Shoskes DA; Barazani Y; Fareed K; Sabanegh E
    Int Braz J Urol; 2015; 41(6):1167-71. PubMed ID: 26742976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone replacement therapy for late onset hypogonadism: what is the risk of inducing prostate cancer?
    Gould DC; Kirby RS
    Prostate Cancer Prostatic Dis; 2006; 9(1):14-8. PubMed ID: 16264770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
    Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
    Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-onset Hypogonadism: Bone health.
    Rochira V
    Andrology; 2020 Nov; 8(6):1539-1550. PubMed ID: 32469467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.